Yi Chen

Stock Analyst at HC Wainwright & Co.

(0)
# 3307
Out of 5,267 analysts
570
Total ratings
36.79%
Success rate
2.04%
Average return
56 Stocks
Name Action Price Target Current % Upside Ratings Updated
Bausch & Lomb
Maintains: Buy
23 20
16 25% 17 Feb 21, 2025
Anixa Biosciences
Reiterates: Buy
7 7
3.15 122.22% 18 Feb 18, 2025
OKYO Pharma
Reiterates: Buy
7 7
1.26 455.56% 12 Feb 18, 2025
Kala Bio
Reiterates: Buy
15 15
6.89 117.71% 20 Feb 13, 2025
Greenwich LifeScienc...
Reiterates: Buy
38 38
12.2 211.48% 7 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
11 12
4.79 150.52% 18 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
57
28.03 103.35% 1 Feb 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 7
1.46 379.45% 5 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50 50
34.6 44.51% 2 Jan 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
36 36
6.58 447.11% 8 Jan 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
26 26
22.11 17.59% 10 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
1.01 197.03% 12 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
14 15
9.28 61.64% 9 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1.75 71.43% 10 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
19.59 53.14% 12 Jan 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
0.52 476.92% 20 Jan 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
49 49
13.05 275.48% 5 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
17 17
7.23 135.13% 20 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
22 22
6.25 252% 20 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15 15
7.12 110.67% 25 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
1.36 83.82% 19 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 10 Nov 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
9 9
2.99 201% 16 Nov 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
14 14
4.64 201.72% 2 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
0.86 597.67% 18 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
60 100
57.28 74.58% 17 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
3.25 207.69% 15 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
5.26 128.14% 7 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
2 2
0.5 200% 22 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
1.1 172.73% 1 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
n/a n/a 9 Jul 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
6
n/a n/a 17 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 2
0.14 971.43% 18 Jun 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
0.37 2602.7% 5 May 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
72 72
n/a n/a 19 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Neutral
n/a
n/a n/a 12 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
0.44 2400% 14 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
38
n/a n/a 9 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 3
n/a n/a 4 Aug 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 6 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
2
n/a n/a 8 Jun 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15
n/a n/a 7 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 7 Jun 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6
n/a n/a 10 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
30 34
n/a n/a 7 Jul 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 2
n/a n/a 5 May 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
240 180
0.16 112400% 1 May 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
58 48
16.59 189.33% 8 Apr 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25
n/a n/a 3 Dec 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 6 Nov 17, 2021